Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates

S. Corvec; M. Illiaquer; S. Touchais; D. Boutoille; N. van der Mee-Marquet; R. Quentin; A. Reynaud; D. Lepelletier; P. Bémer; and the Bone and Joint Infection Study Group

首页> 外文期刊>Journal of Clinical Microbiology >Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates

【24h】

Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates

机译：B组链球菌假体关节感染的临床特征和分离株的分子特征

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Twelve group B Streptococcus (GBS) prosthetic joint infection (PJI) cases are reported. The mean patient age was 55 years. Eleven infections were caused by GBS alone. The associated isolates belonged to phylogenetic lineages different from those that cause neonatal meningitis. The clinical outcome was favorable for the eight patients for whom follow-up data were available.

机译：报道了十二个B组链球菌（GBS）假体关节感染（PJI）病例。患者平均年龄为55岁。仅GBS引起11次感染。相关的分离物属于与导致新生儿脑膜炎的分离物不同的系统发育谱系。对于有随访数据的八名患者，其临床结局是有利的。 展开▼

著录项

来源
《Journal of Clinical Microbiology》 |2011年第1期|共3页

作者
S. Corvec; M. Illiaquer; S. Touchais; D. Boutoille; N. van der Mee-Marquet; R. Quentin; A. Reynaud; D. Lepelletier; P. Bémer; and the Bone and Joint Infection Study Group;
展开▼

作者单位

展开▼

收录信息

原文格式 PDF

正文语种

中图分类医学微生物学（病原细菌学、病原微生物学）;

关键词

相似文献

外文文献

中文文献

专利

1. Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates [J] . S. Corvec, M. Illiaquer, S. Touchais, Journal of Clinical Microbiology . 2011,第1期

机译：B组链球菌假体关节感染的临床特征和分离株的分子特征

2. Spacer usage in prosthetic joint infections does not influence infect resolution: Retrospective analysis of 120 joints with two-stage exchange. Re: Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections. Cabo J, Euba G, Saborido A, González-Panisello M, Domínguez MA, Agullthomampersa [J] . WimmerM.D., VavkenP., PagenstertG.I., Journal of Infection . 2013,第1期

机译：假体关节感染中的垫片使用不会影响感染的解决：回顾性分析120关节的两阶段置换。回复：假体关节感染的两阶段修复中使用抗生素填充的间隔物的临床结果和微生物学发现。 Cabo J，Euba G，Saborido A，González-PaniselloM，DomínguezMA，Agullthomampersa

3. Comment on: Prosthetic hip joint infection with a Streptococcus agalactiae isolate not susceptible to penicillin G and ceftriaxone [J] . Parham Sendi123* and Werner Zimmerli3 Journal of Antimicrobial Chemotherapy . 2012,第4期

机译：评论：无乳链球菌分离株对青霉素G和头孢曲松不敏感的假肢髋关节感染

4. PRELIMINARY REPORT ON THE CHARACTERIZATION OF STREPTOCOCCUS SUIS SEROTYPE 2 CLINICAL ISOLATES IN CHINA [C] . Zigong Wei, Zhenyan Yin, Yafeng Hua, Congress ofthe International Pig Veterinary Society . 2008

机译：初步报告中国血清科血清型2型临床分离株的表征

5. Evolution and Molecular Characterization of Clinical Respiratory Macrolide-Resistant Streptococcus pneumoniae in Canada. [D] . Wierzbowski, Aleksandra K. 2012

机译：在加拿大临床抵抗大环内酯类肺炎链球菌的演变和分子特征。

6. Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates [O] . S. Corvec, M. Illiaquer, S. Touchais, 2011

机译：B组链球菌假体关节感染的临床特征和分离株的分子表征

7. Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates ▿ [O] . Corvec, S., Illiaquer, M., Touchais, S., 2010

机译：B组链球菌假体关节感染的临床特征和分离株的分子特征

1. 儿童医院相关性耐甲氧西林金黄色葡萄球菌感染的临床特征和分离株分子特征 [J] . 宁雪 ,乔艳红 ,姚开虎 . 中国循证儿科杂志 . 2019,第001期

2. 儿童侵袭性肺炎链球菌病35例临床特征和分离株耐药性分析 [J] . 张慧芬 ,李基明 ,吴佳音 . 中国感染与化疗杂志 . 2021,第002期

3. B组链球菌临床分离株表型和分子流行病学方法的研究 [J] . 申阿东 ,杨永弘 ,黄醒华 . 医学研究杂志 . 2004,第010期

4. 北京地区儿童A组链球菌感染临床分离株的emm分型研究 [J] . 刘医萌 ,杨鹏 ,吴双胜 . 国际检验医学杂志 . 2017,第024期

5. 苏州地区耐左氧氟沙星无乳链球菌临床分离株分子及质谱学特征分析 [J] . 张宇蔺 ,苏宁 ,陈海鹏 . 临床检验杂志 . 2020,第010期

6. 儿童金黄色葡萄球菌皮肤软组织感染临床分离株分子及耐药特征的研究 [C] . 刘颖超 ,杨鑫 ,王丽娟 . 2018北京医学会儿科学分会学术年会暨北京医师协会儿内科医师分会学术年会 . 2018

7. 河南省H1N2亚型猪流感病毒分离株基因组演化特征和生物学特性研究 [A] . 张云 . 2012

1. 一株HuNoV GII.4临床分离株序列及其感染性克隆的构建与应用 [P] . 中国专利： CN110144331B . 2021.10.08

2. 一株HuNoV GII.4临床分离株序列及其感染性克隆的构建与应用 [P] . 中国专利： CN110144331A . 2019-08-20

3. VACCINE CAPABLE TO MAKE IMMUNITY IN HOST AGAINST INFECTION CAUSED BY STREPTOCOCCUS GROUP B, METHOD OF PREVENTION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B AND A METHOD OF ATTENUATION OF INFECTION CAUSED BY STREPTOCOCCUS GROUP B [P] . 外国专利： RU2113234C1 . 1998-06-20

机译：能够抵抗乙型链球菌引起的感染的疫苗的疫苗，预防乙型链球菌引起的感染的方法以及减轻乙型链球菌引起的感染的方法

4. Isolated polynucleotide, vector comprising this polynucleotide, vector transformed or transfected host cell, method for production of isolated polypeptide coded by isolated polynucleotide, composition for vaccines comprising this polypeptide, the use of this composition in treating or preventing streptococcus infection, diagnostic test method for streptococcus infection, detection method for antibody specifically binding to streptococcus antigen, detection method for streptococci presence in biological sample [P] . 外国专利： PL204073B1 . 2009-12-31

机译：分离的多核苷酸，包含该多核苷酸的载体，载体转化或转染的宿主细胞，生产由分离的多核苷酸编码的分离的多肽的方法，用于包含该多肽的疫苗的组合物，该组合物在治疗或预防链球菌感染中的用途，链球菌的诊断测试方法感染，特异性结合链球菌抗原的抗体的检测方法，生物样品中链球菌的存在的检测方法

5. Isolated molecular structure, enveloping and combining viruses, vaccine formulation, anti-corporomonoclonal, polyclonal antiserum, jelly, foam, contraceptive cream or ointment, mammal and human blood samples, kit, cell line, treatment processes or prevention of infection by a virus in subject, treatment or prevention of infection by a human infection, inhibition of infection by a virus in a blood sample, inhibition of infection by HIV in a human blood sample, decontamination of surgical or dental tools, monitoring of antibody product to molecular structure, production of an immunogen for use in a vaccine for treatment or prevention of infection by a virus, and production of an immunogen for use in a vaccine for the treatment or prevention of HIV infection, cross-linked structure, monoclonal antibody to the structure , decontamination of surgical or dental tools, pro selection process of a molecular structure for vaccine efficacy, mammal, isolated protein complex, devacin formulation, p [P] . 外国专利： BR9912732A . 2001-11-27

机译：分离的分子结构，包膜和合并病毒，疫苗制剂，抗体单克隆抗体，多克隆抗血清，果冻，泡沫，避孕霜或软膏，哺乳动物和人类血液样本，试剂盒，细胞系，治疗过程或预防对象被病毒感染，治疗或预防人类感染的感染，抑制血液样本中的病毒感染，抑制人类血液样本中的HIV感染，对外科工具或牙科工具进行去污，监控抗体产物的分子结构，用于疫苗中的用于治疗或预防病毒感染的免疫原，以及用于疫苗中的用于治疗或预防HIV感染的免疫原的生产，交联结构，针对该结构的单克隆抗体，外科手术的净化或牙科工具，用于疫苗效力的分子结构的专业选择过程，哺乳动物，分离的蛋白复合物，解体素制剂，p

相关主题

Clinical Features of Group B Streptococcus Prosthetic Joint Infections and Molecular Characterization of Isolates

摘要

著录项

相似文献

相关主题

期刊订阅